Study of the clinical utility and safety in combination use of the GLP-1 analogue and BG in type 2 diabetic patients

Trial Profile

Study of the clinical utility and safety in combination use of the GLP-1 analogue and BG in type 2 diabetic patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2015

At a glance

  • Drugs Liraglutide (Primary) ; Biguanides
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jul 2015 Status changed from active no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
    • 21 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top